STOCK TITAN
  1. Home
  2. Sec-filings
  3. OSCR
  4. [Form 4] Oscar Health, Inc. Insider Trading Activity

OSCR director elects 1,034 DSUs in lieu of cash retainer

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Oscar Health (OSCR) reported a director equity transaction. A director received 1,034 deferred stock units on October 9, 2025 at $20.54 per unit under the company’s Amended and Restated Deferred Compensation Plan for Directors, electing DSUs in lieu of a cash retainer. Each DSU represents the right to receive one share of Class A common stock and is 100% vested on the grant date. DSUs will be settled for cash or shares, at the company’s discretion, within 45 days of the earliest of termination of service, a change in control, death, or disability. Following this grant, the reporting person held 4,136 derivative securities directly.

Positive

  • None.

Negative

  • None.
Insider Plouffe David
Role Director
Type Security Shares Price Value
Grant/Award Deferred Stock Unit 1,034 $20.54 $21K
Holdings After Transaction: Deferred Stock Unit — 4,136 shares (Direct)
Footnotes (1)
  1. Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on October 9, 2025, which price was used to calculate the number of deferred stock units issued to the Reporting Person. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did Oscar Health (OSCR) disclose in this Form 4?
A director received 1,034 deferred stock units on October 9, 2025 at $20.54 per unit under the director deferred compensation plan.

What does each DSU represent for OSCR?
Each DSU represents a right to receive one share of Oscar Health’s Class A common stock.

When do the DSUs vest and how are they settled?
The DSUs are 100% vested on the grant date and will be settled for cash or shares, at the issuer’s discretion, within 45 days of certain events.

What events trigger DSU settlement for OSCR’s director?
Settlement occurs upon the earliest of termination of service, change in control, death, or disability.

How many derivative securities did the director hold after the transaction?
The reporting person held 4,136 derivative securities directly after the reported transaction.

Why was the grant price set at $20.54 for OSCR?
The price reflects the closing price of OSCR Class A common stock on October 9, 2025, used to calculate DSUs issued in lieu of cash.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Plouffe David
(Last) (First) (Middle)
75 VARICK STREET, 5TH FLOOR
(Street)
NEW YORK NY 10013
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Unit (1) 10/09/2025 A 1,034 (3) (3) Class A Common Stock 1,034 $20.54(2) 4,136 D
Explanation of Responses:
1. Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock.
2. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on October 9, 2025, which price was used to calculate the number of deferred stock units issued to the Reporting Person.
3. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.
Remarks:
/s/Melissa Curtin, Attorney-in-Fact 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR